New York Senate bill in Session 2025-2026.
Status: in_committee. Latest action: April 20, 2026.
Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.
Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.
| Date | Event | Detail |
|---|---|---|
| 2026-03-18 | Introduced | Bill introduced |
| 2026-04-20 | Status | in_committee |
| 2026-04-20 | Latest Action | In Senate Committee |